现代生物医学进展2024,Vol.24Issue(22) :4376-4378,4400.DOI:10.13241/j.cnki.pmb.2024.22.053

生长激素缺乏症患儿行重组人生长激素治疗前后维生素D水平的变化及其预后影响因素分析

Growth Hormone Deficiency Role of Recombinant Human Growth Hormone Treatment before and after the Change of the Vitamin D Levels and Its Prognostic Factors Analysis

齐雪 任婷婷 常侨 王彦华 李兆坤
现代生物医学进展2024,Vol.24Issue(22) :4376-4378,4400.DOI:10.13241/j.cnki.pmb.2024.22.053

生长激素缺乏症患儿行重组人生长激素治疗前后维生素D水平的变化及其预后影响因素分析

Growth Hormone Deficiency Role of Recombinant Human Growth Hormone Treatment before and after the Change of the Vitamin D Levels and Its Prognostic Factors Analysis

齐雪 1任婷婷 1常侨 1王彦华 1李兆坤1
扫码查看

作者信息

  • 1. 西安医学院第二附属医院儿科 陕西西安 710038
  • 折叠

摘要

目的:分析生长激素缺乏症患儿行重组人生长激素治疗前后维生素D水平的变化及其预后影响因素.方法:选择2020.2-2023.2期间收治的80例生长激素缺乏症患儿,予以重组人生长激素治疗.比较相关指标并分析预后影响因素.结果:生长激素缺乏症患儿治疗后身高、身高标准差积分、生长速率均较治疗前增大(P<0.05);生长激素缺乏症患儿治疗后血清IGF-1、IGF-BP-3表达水平均较治疗前升高(P<0.05);生长激素缺乏症患儿治疗后血清25(OH)D3、1,25-(OH)2D3表达水平均较治疗前升高(P<0.05);经单因素和多因素Logistic回归分析,治疗前生长速率、治疗前骨龄成熟度、母体孕期合并症均是生长激素缺乏症患儿行重组人生长激素治疗后预后的独立影响因素(P<0.05).结论:生长激素缺乏症患儿行重组人生长激素治疗的促生长效果确切,有助于促进维生素D的代谢,但预后受治疗前生长速率、治疗前骨龄成熟度和母体孕期合并症的影响.

Abstract

Objective:To analyze the changes of vitamin D levels and prognostic factors in children with growth hormone defi-ciency before and after treatment with recombinant human growth hormone.Methods:80 children with GH deficiency admitted during 2020.2-2023.2 were selected for recombinant human GH therapy.Compare relevant indicators and analyze prognostic factors.Results:The height,height standard deviation score and growth rate of children with GH deficiency increased compared with those before treat-ment(P<0.05);The serum expression levels of IGF-1 and IGFBP-3 in children with GH deficiency increased compared with those before treatment(P<0.05);Serum 25(OH)D3,1,The expression level of 25-(OH)2D3 was increased compared with that before treatment(P<0.05);After the univariate and multivariate Logistic regression analysis,Pre-treatment growth rate,bone age maturity,and maternal preg-nancy comorbidities were all independent factors for outcomes in children with GH deficiency(P<0.05).Conclusion:The growth-pro-moting effect of recombinant human growth hormone treatment helps to promote the metabolism of vitamin D,but the prognosis is influ-enced by pre-treatment growth rate,pre-treatment bone age maturity and maternal pregnancy comorbidities.

关键词

生长激素缺乏症/重组人生长激素/维生素D

Key words

Growth hormone deficiency/Recombinant human growth hormone/Vitamin D

引用本文复制引用

出版年

2024
现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
段落导航相关论文